The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 10 (12) , 2687-2693
Abstract
Esophageal squamous cell cancer (ESCC) is one of the leading malignant cancer in the world and especially in China with high incidence and mortality. The exploration of novel serum biomarkers is required for early detection of ESCC. We investigated the diagnostic value of serum insulin like growth factor binding protein 7 (IGFBP7) in ESCC, evaluating its potential to improve the diagnosis of ESCC. The serum samples of 106 patients with ESCC and 107 normal controls were tested by enzyme-linked immunosorbent assay (ELISA). The levels of IGFBP7 in ESCC group were significantly higher than that in normal controls, compared by the Mann-Whitney U test (P). Using receiver operating characteristic (ROC) curve, the diagnostic value of serum IGFBP7 was demonstrated. Versus normal group, the area under the ROC curve (AUC) of all ESCC was 0.794 (95%CI: 0.735-0.853) and early-stage ESCC was 0.725 (95%CI: 0.633-0.817). With optimized cutoff value of 2.993 ng/mL, IGFBP7 showed certain diagnostic value with specificity of 90.7%, sensitivities of 40.6% and 32.4% in ESCC and early-stage ESCC, respectively. Considering the correlation between clinical data and IGFBP7, no significant association was found (all P>0.05). Thus, we supposed that serum IGFBP7 might be a potential biomarker in the diagnosis of ESCC.Keywords
This publication has 39 references indexed in Scilit:
- Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancerOncoTargets and Therapy, 2013
- Endoscopic tumor diagnosis and treatmentGastrointestinal Endoscopy, 2013
- Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateInternational Journal of Cancer, 2013
- Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancerOncology Reports, 2013
- European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publicationEndoscopy, 2012
- Biomarkers in Pancreatic CancerThe Cancer Journal, 2012
- Clinical validation of an autoantibody test for lung cancerAnnals of Oncology, 2010
- Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registryScandinavian Journal of Gastroenterology, 2008
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- CYFRA 21-1 determination in patients with esophageal squamous cell carcinomaCancer, 2000